Abstract
The frequency change of mucosal-associated invariant T (MAIT) cells may play a significant role in the pathogenesis of Polycystic Ovary Syndrome (PCOS). This study explores the alterations of circulating MAIT cells and their clinical correlations, suggesting that these cells may provide a new target for PCOS treatment and prevention.
Introduction
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by hormonal imbalances, ovulatory dysfunction, and metabolic disturbances. Despite its prevalence, the underlying etiology remains poorly understood. Recent evidence suggests that systemic low-grade inflammation and gut microbial dysbiosis are key contributors to the disease's progression.
MAIT cells are a specialized subset of innate-like T cells that recognize microbial metabolites. Positioned at the interface of the immune system and the gut microbiota, they regulate inflammatory responses through cytokine secretion. This study hypothesized that alterations in circulating MAIT cell populations might be linked to the chronic inflammation and metabolic dysfunction observed in PCOS.
Methods
A cross-sectional study was conducted involving 33 PCOS patients (diagnosed by Rotterdam criteria) and 30 age-matched healthy controls.
- Flow Cytometry: Peripheral blood mononuclear cells were analyzed to quantify MAIT cells, defined as CD3+ CD161+ TCR Vα7.2+ lymphocytes.
- Cytokine Analysis: Serum levels of IL-17, IL-22, IFN-γ, and Granzyme B were measured using ELISA.
- Clinical Correlation: MAIT cell frequencies were correlated with clinical parameters including Body Mass Index (BMI), insulin resistance (HOMA-IR), and hormonal markers like Anti-Müllerian Hormone (AMH) and testosterone.
Results
The study identified a significant reduction in the frequency of circulating MAIT cells in patients with PCOS compared to healthy controls.
Key Findings:
- Decreased Frequency: The mean frequency of circulating MAIT cells was significantly lower in the PCOS group (5.29%) than in the control group (7.76%, p < 0.01).
- Metabolic and Hormonal Correlations: MAIT cell levels were negatively correlated with BMI, HOMA-IR, and AMH levels. Specifically, patients with BMI ≥ 24 kg/m², HOMA-IR ≥ 1.5, or AMH ≥ 8 ng/ml exhibited the lowest MAIT cell counts.
- Cytokine Imbalance: PCOS patients showed significantly higher serum IL-17 levels, which negatively correlated with MAIT cell frequency (R = -0.37, p = 0.003). Conversely, levels of the protective cytokine IL-22 were lower in the PCOS group.
- Diagnostic Utility: Receiver Operating Characteristic (ROC) analysis yielded an Area Under the Curve (AUC) of 0.6904, indicating moderate diagnostic potential for MAIT cell frequency as a biomarker for PCOS.
Discussion and Limitations
The depletion of circulating MAIT cells in PCOS suggests a state of immune dysregulation. This deficiency may result from chronic inflammatory exhaustion or the recruitment of these cells from the peripheral blood into inflamed tissues, such as adipose tissue or the ovaries. The strong correlation with metabolic markers reinforces the view of PCOS as a systemic metabolic-immunological disorder.
While promising, this study has limitations, including a relatively small sample size (n=63) and a cross-sectional design that cannot establish causality. Future research should investigate MAIT cell localization within ovarian tissues and explore the mechanistic pathways—such as apoptosis or tissue-specific recruitment—driving these alterations. Targeting the gut-immune axis through MAIT cell modulation represents a potential novel therapeutic avenue for PCOS.
Summary updated